Kindstar Globalgene Technology, Inc.
9960.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$971.31M
Close$
Share Statistics
| Market cap | $971.31 Million |
|---|---|
| Enterprise Value | $744.68 Million |
| Dividend Yield | $0.10 (10.11%) |
| Earnings per Share | $-0.06 |
| Beta | 0.63 |
| Outstanding Shares | 997,062,262 |
Return
| Return on Equity | -5.58% |
|---|---|
| Return on Assets | -3.88% |
| Return on Invested Capital | -12.07% |
Valuation & Multiples
| P/E Ratio | -19.57 |
|---|---|
| PEG | 41.01 |
| Price to Sales | 0.94 |
| Price to Book Ratio | 0.47 |
| Enterprise Value to Revenue | 0.4 |
| Enterprise Value to EBIT | -2.12 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.53 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$616.39 M
Average shareholder expectationNext Earnings Call
Expected Date
March 26, 2027
EPS Estimate
$0.04
Average shareholder expectationRevenue Estimate
$636.61 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kindstar Globalgene Technology, Inc.
2,999 employees
CEO: Shiang Huang Kindstar Global (Beijing) Technology, Inc. is a prominent provider of highly specialized diagnostic services to healthcare institutions across China. Beyond just diagnostics, the company extends its expertise to support medical research,...